Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and related uses
TW202626665APending Publication Date: 2026-07-01CENTESSA PHARMACEUTICALS (UK) LIMITED
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115111609
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-01-17
- Filing Date
- 2023-03-01
- Publication Date
- 2026-07-01
Abstract
The present disclosure relates to compounds of Formula (I’): , and to their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for modulating orexin-2 receptor activity and may be used in the treatment of disorders in which orexin-2 receptor activity is implicated, such as narcolepsy, a hypersomnia disorder, a neurodegenerative disorder, a symptom of a rare genetic disorder, a mental health disorder, a metabolic syndrome, osteoporosis, cardiac failure, coma, or facilitating emergence from anaesthesia.
Need to check novelty before this filing date? Find Prior Art